138 related articles for article (PubMed ID: 2855411)
61. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
62. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
[TBL] [Abstract][Full Text] [Related]
63. Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment.
Waalkes TP; Abeloff MD; Woo KB; Ettinger DS; Ruddon RW; Aldenderfer P
Cancer Res; 1980 Dec; 40(12):4420-7. PubMed ID: 6254646
[TBL] [Abstract][Full Text] [Related]
64. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
[TBL] [Abstract][Full Text] [Related]
66. [Clinical evaluation of serum beta 2-microglobulin in squamous cell carcinoma of the lung].
Higuchi Y; Togawa T; Moriya H; Hoshi K; Satoh T; Kimura K
Gan No Rinsho; 1986 Dec; 32(15):1919-24. PubMed ID: 3543434
[TBL] [Abstract][Full Text] [Related]
67. Prognostic significance of carcinoembryonic antigen level in pleural lavage fluid for patients with lung adenocarcinoma.
Tomita M; Shimizu T; Matsuzaki Y; Hara M; Ayabe T; Onitsuka T
Ann Thorac Surg; 2005 Jul; 80(1):276-81. PubMed ID: 15975381
[TBL] [Abstract][Full Text] [Related]
68. [Evaluation of cellular immunity in pulmonary sarcoidosis and primary lung cancer].
Li JP
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):100-2, 128. PubMed ID: 1327551
[TBL] [Abstract][Full Text] [Related]
69. [Prognostic value of serum and tissue CEA evaluation in lung cancer].
Leonardo E; Navone R; Dogliotti C; Oliaro A
Minerva Med; 1985 Nov; 76(44):2111-6. PubMed ID: 4069423
[TBL] [Abstract][Full Text] [Related]
70. An immunohistochemical study of keratin, carcinoembryonic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer.
Kimura N; Ghandur-Mnaymen L
Tohoku J Exp Med; 1985 Jan; 145(1):23-38. PubMed ID: 2580364
[TBL] [Abstract][Full Text] [Related]
71. [A study of sputum beta 2-microglobulin and carcinoembryonic antigen in patients with primary lung cancer].
Fujii M; Tamai M
Gan No Rinsho; 1985 Jun; 31(7):799-802. PubMed ID: 3897623
[TBL] [Abstract][Full Text] [Related]
72. Application of immunoperoxidase staining to the cell blocks from sputa and bronchial washings.
Lyubsky S; Thorn R
Arch Pathol Lab Med; 1989 Jan; 113(1):94-5. PubMed ID: 2462860
[TBL] [Abstract][Full Text] [Related]
73. IL-2 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) patients.
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():136-45. PubMed ID: 9337532
[TBL] [Abstract][Full Text] [Related]
74. Immunologic studies of glycoproteins isolated from cell membranes of human lung carcinomas.
Tillack TW; Rosai J; Vervynck DJ
J Natl Cancer Inst; 1974 Apr; 52(4):1059-67. PubMed ID: 4133198
[No Abstract] [Full Text] [Related]
75. Immunohistochemical study of carcinoembryonic antigen (CEA) in lung carcinoma by five monoclonal antibodies.
Hiraoka K; Horie A
J UOEH; 1988 Sep; 10(3):237-46. PubMed ID: 2845551
[TBL] [Abstract][Full Text] [Related]
76. [Clinical studies of idiopathic interstitial pneumonia associated with lung cancer].
Kohno N; Takami S; Kamitsuna A; Ohnari K; Yamakido M; Nishimoto Y; Tsukiyama F
Nihon Naika Gakkai Zasshi; 1983 Dec; 72(12):1731-9. PubMed ID: 6327859
[No Abstract] [Full Text] [Related]
77. Clinicopathological study on the relationship between serum-CEA and tissue-CEA of resected lung cancer cases.
Okamura A; Ohkawa J; Fujisawa H; Sashikata T
Acta Pathol Jpn; 1984 Nov; 34(6):1209-19. PubMed ID: 6098125
[TBL] [Abstract][Full Text] [Related]
78. Adenocarcinoma of the lung. Immunohistochemical findings (keratin/CEA).
Brockmann M; Brockmann I; Herberg U; Müller KM
J Cancer Res Clin Oncol; 1987; 113(4):379-82. PubMed ID: 2439516
[TBL] [Abstract][Full Text] [Related]
79. [Alpha fetoprotein levels in the serum and bronchoalveolar lavage fluid in patients with lung cancer and other diseases of the respiratory system].
Płusa T; Bejm J; Józefczak E; Piechota W; Mamełka B
Pneumonol Alergol Pol; 1992; 60(1-2):15-9. PubMed ID: 1283967
[TBL] [Abstract][Full Text] [Related]
80. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
